摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(7-quinolinyl)-5-O-tert-butyldimethylsilyl-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol | 1061229-96-6

中文名称
——
中文别名
——
英文名称
N-(7-quinolinyl)-5-O-tert-butyldimethylsilyl-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol
英文别名
——
N-(7-quinolinyl)-5-O-tert-butyldimethylsilyl-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol化学式
CAS
1061229-96-6
化学式
C24H36N2O3Si
mdl
——
分子量
428.647
InChiKey
GAKDMAMYJIJKBP-BHIFYINESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.96
  • 重原子数:
    30.0
  • 可旋转键数:
    5.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    43.82
  • 氢给体数:
    0.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    N-(7-quinolinyl)-5-O-tert-butyldimethylsilyl-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol三氟乙酸 为溶剂, 以49%的产率得到1,4-dideoxy-1,4-imino-N-(7-quinolinyl)methyl-D-ribitol trifluoroacetate
    参考文献:
    名称:
    N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase
    摘要:
    A key enzyme within the purine salvage pathway of parasites, nucleoside hydrolase, is proposed as a good target for new antiparasitic drugs. We have developed N-arylmethyl-iminoribitol derivatives as a novel class of inhibitors against a purine specific nucleoside hydrolase from Trypanosoma vivax. Several of our inhibitors exhibited low nanomolar activity, with 1,4-dideoxy-1,4-imino-N-(8-quinolinyl)methyl-D-ribitol (UAMC-00115, K-i 10.8 nM), N-(9-deaza-adenin-9-yl)methyl-1,4-dideoxy-1,4-imino- D-ribitol (K-i 4.1 nM), and N-(9-deazahypoxanthin-9-yl) methyl-1,4-dideoxy-1,4-imino- D-ribitol (K-i 4.4 nM) being the three most active compounds. Docking studies of the most active inhibitors revealed several important interactions with the enzyme. Among these interactions are aromatic stacking of the nucleobase mimic with two Trp-residues, and hydrogen bonds between the hydroxyl groups of the inhibitors and amino acid residues in the active site. During the course of these docking studies we also identified a strong interaction between the Asp40 residue from the enzyme and the inhibitor. This is an interaction which has not previously been considered as being important. (c) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.05.056
  • 作为产物:
    描述:
    7-(溴甲基)喹啉(3AR,4R,6AS)-4-[[[(叔丁酯)二甲基硅烷基]氧基]甲基]四氢-2,2-二甲基-4H-1,3-二氧杂环戊烯并[4,5-C]吡咯potassium hydrogencarbonate 作用下, 以 四氯化碳N,N-二甲基甲酰胺 为溶剂, 反应 1.5h, 以0.15 g的产率得到N-(7-quinolinyl)-5-O-tert-butyldimethylsilyl-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol
    参考文献:
    名称:
    N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase
    摘要:
    A key enzyme within the purine salvage pathway of parasites, nucleoside hydrolase, is proposed as a good target for new antiparasitic drugs. We have developed N-arylmethyl-iminoribitol derivatives as a novel class of inhibitors against a purine specific nucleoside hydrolase from Trypanosoma vivax. Several of our inhibitors exhibited low nanomolar activity, with 1,4-dideoxy-1,4-imino-N-(8-quinolinyl)methyl-D-ribitol (UAMC-00115, K-i 10.8 nM), N-(9-deaza-adenin-9-yl)methyl-1,4-dideoxy-1,4-imino- D-ribitol (K-i 4.1 nM), and N-(9-deazahypoxanthin-9-yl) methyl-1,4-dideoxy-1,4-imino- D-ribitol (K-i 4.4 nM) being the three most active compounds. Docking studies of the most active inhibitors revealed several important interactions with the enzyme. Among these interactions are aromatic stacking of the nucleobase mimic with two Trp-residues, and hydrogen bonds between the hydroxyl groups of the inhibitors and amino acid residues in the active site. During the course of these docking studies we also identified a strong interaction between the Asp40 residue from the enzyme and the inhibitor. This is an interaction which has not previously been considered as being important. (c) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2008.05.056
点击查看最新优质反应信息